HC
GILD icon

Hoese & Co’s Gilead Sciences GILD Stock Holding History

Hoese & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14
Closed -$1K – 186
2022
Q3 		$1K Hold
14
– – ﹤0.01% 197
2022
Q2 		$1K Hold
14
– – ﹤0.01% 200
2022
Q1 		$1K Hold
14
– – ﹤0.01% 204
2021
Q4 		$1K Hold
14
– – ﹤0.01% 208
2021
Q3 		$1K Hold
14
– – ﹤0.01% 195
2021
Q2 		$1K Buy
+14
New +$935 ﹤0.01% 203

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hoese & Co's GILD Position: Q4 2022 in Review

Hoese & Co sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 14 shares — an estimated $1K sold.

Hoese & Co first reported a position in GILD in Q2 2021 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Hoese & Co reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • Hoese & Co sold 14 Gilead Sciences shares in Q4 2022, an estimated $1K.
  • Hoese & Co first reported a position in Gilead Sciences in Q2 2021 and held it in 6 quarters.
  • Hoese & Co's Gilead Sciences position peaked at $1K in Q3 2022.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Hoese & Co's 13F filing for Q4 2022, filed 10 Jan 2023.